Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc.

(Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the ...

The global Life Science Instrumentation Market, valued at US$63.4 billion in 2025, is projected to advance at a resilient CAGR of 6.5% ...

FROM 27th September–1st October 2025, Amsterdam, the Netherlands, welcomed over 22,000 respiratory professionals to the ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the ...

Survivors of severe COVID-19 may exhibit immune dysregulation, characterised by reduced naïve and increased senescent and ...

Selecttm, a custom antibody service providing scientists with unparalleled access to the highest quality antibody reagents in the industry for any protein target. These include challenging ...

This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...